Stevens Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-7,152
| Closed | -$151K | – | 1341 |
|
|
2015
Q3 | $151K | Buy |
7,152
+4,312
| +152% | +$91K | 0.01% | 866 |
|
|
2015
Q2 | $141K | Sell |
2,840
-1,265
| -31% | -$62.8K | 0.01% | 923 |
|
|
2015
Q1 | $321K | Buy |
4,105
+822
| +25% | +$64.3K | 0.01% | 726 |
|
|
2014
Q4 | $199K | Sell |
3,283
-1,040
| -24% | -$63K | 0.01% | 865 |
|
|
2014
Q3 | $184K | Buy |
4,323
+2,147
| +99% | +$91.4K | 0.01% | 874 |
|
|
2014
Q2 | $134K | Sell |
2,176
-1,288
| -37% | -$79.3K | ﹤0.01% | 982 |
|
|
2014
Q1 | $225K | Buy |
3,464
+1,034
| +43% | +$67.2K | 0.01% | 893 |
|
|
2013
Q4 | $137K | Sell |
2,430
-8,095
| -77% | -$456K | ﹤0.01% | 951 |
|
|
2013
Q3 | $645K | Buy |
10,525
+5,490
| +109% | +$336K | 0.02% | 582 |
|
|
2013
Q2 | $294K | Buy |
+5,035
| New | +$294K | 0.01% | 717 |
|